IL1B promoter polymorphism regulates the expression of gastric acid stimulating hormone gastrin

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 7, 2009, Pages 1502-1510

  Chakravorty, Meenakshi ^a   Datta De, Dipanjana ^a   Choudhury, Abhijit ^b   Roychoudhury, Susanta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Institute of Postgraduate Medicine and Experimental Research   (India)

Author keywords

Duodenal ulcer; Gastrin; Helicobacter pylori; IL1B promoter polymorphism; NF B

Indexed keywords

GASTRIN; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA;

ALLELE; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

CELL LINE, TUMOR; DOWN-REGULATION; ENZYME INHIBITORS; GASTRIC ACID; GASTRINS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; INTERLEUKIN-1BETA; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TIME FACTORS; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION, GENETIC;

HELICOBACTER PYLORI;

EID: 63049086873     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.12.017     Document Type: Article

References (48)

1. Beales I., and Calam J. Interleukin 1B and tumour necrosis factor alpha inhibit aminopyrine accumulation in cultured rabbit parietal cells by multiple pathways. Gastroenterology 112 (1996) A259
2. Beales I.L., and Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42 (1998) 227-234
3. Belvin M.P., and Anderson K.V. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 12 (1996) 393-416
4. Blaser M.J., and Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 113 (2004) 321-333
5. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119 (2004) 591-602
6. Chakravorty M., Ghosh A., Choudhury A., Santra A., Hembrum J., and Roychoudhury S. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 27 (2006) 411-419
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52 (1992) 6735-6740
8. Dragomir E., Tircol M., Manduteanu I., Voinea M., and Simionescu M. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Vascul Pharmacol 44 (2006) 440-449
9. El-Omar E.M. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 48 (2001) 743-747
10. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
11. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412 (2001) 99
12. El-Omar E.M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 (1997) 15-24
13. Ennas M.G., Moore P.S., Zucca M., Angelucci E., Cabras M.G., Melis M., et al. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 26 (2008) 98-103
14. Ernst P.B., Peura D.A., and Crowe S.E. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 130 (2006) 188-206 [quiz 212-183]
15. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., Sugimura H., et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
16. Furuta T., Shirai N., and Sugimoto M. Controversy in polymorphisms of interleukin-1beta in gastric cancer risks. J Gastroenterol 39 (2004) 501-503
17. Furuta T., Shirai N., Takashima M., Xiao F., and Sugimura H. Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori. Am J Med 112 (2002) 141-143
18. Garcia-Gonzalez M.A., Lanas A., Santolaria S., Crusius J.B., Serrano M.T., and Pena A.S. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 125 (2001) 368-375
19. Garcia-Gonzalez M.A., Lanas A., Savelkoul P.H., Santolaria S., Benito R., Crusius J.B., et al. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol 134 (2003) 525-531
20. Graham D.Y. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113 (1997) 1983-1991
21. Hart K., Haugen A., and Zienolddiny S. Allele-specific induction of IL1B-31T/C promoter polymorphism by lung carcinogens. Mutat Res 656 (2008) 14-18
22. Hill A.V. The immunogenetics of human infectious diseases. Annu Rev Immunol 16 (1998) 593-617
23. Hou W., and Schubert M.L. Gastric secretion. Curr Opin Gastroenterol 22 (2006) 593-598
24. Ishikawa T., Nagata S., Ago Y., Takahashi K., and Karibe M. The central inhibitory effect of interleukin-1 on gastric acid secretion. Neurosci Lett 119 (1990) 114-117
25. Ito H., Yamamoto N., Arima H., Hirate H., Morishima T., Umenishi F., et al. Interleukin-1beta induces the expression of aquaporin-4 through a nuclear factor-kappaB pathway in rat astrocytes. J Neurochem 99 (2006) 107-118
26. Jain R.N., and Samuelson L.C. Differentiation of the gastric mucosa. II. Role of gastrin in gastric epithelial cell proliferation and maturation. Am J Physiol Gastrointest Liver Physiol 291 (2006) G762-765
27. Kimura R., Nishioka T., Soemantri A., and Ishida T. Cis-acting effect of the IL1B C-31T polymorphism on IL-1 beta mRNA expression. Genes Immun 5 (2004) 572-575
28. Konturek S.J., Starzynska T., Konturek P.C., Karczewska E., Marlicz K., Lawniczak M., et al. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 37 (2002) 891-898
29. Kwiatkowski D. Science, medicine, and the future: susceptibility to infection. BMJ 321 (2000) 1061-1065
30. Lind H., Haugen A., and Zienolddiny S. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 38 (2007) 43-48
31. O'Shea J.M., and Perkins N.D. Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 36 (2008) 603-608
32. Patrone J.B., Bish S.E., and Stein D.C. TNF-alpha-independent IL-8 expression: alterations in bacterial challenge dose cause differential human monocytic cytokine response. J Immunol 177 (2006) 1314-1322
33. Shaw J. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kB and histone deacetylase 1 in ventricular myocytes. Circ Res 99 (2006) 1347-1354
34. Saperas E., Cominelli F., and Tache Y. Potent inhibition of gastric acid secretion by intravenous interleukin-1 beta and -1 alpha in rats. Peptides 13 (1992) 221-226
35. Saperas E., and Tache Y. Central interleukin-1 beta-induced inhibition of acid secretion in rats: specificity of action. Life Sci 52 (1993) 785-792
36. Schubert M.L., and Makhlouf G.M. Neural, hormonal, and paracrine regulation of gastrin and acid secretion. Yale J Biol Med 65 (1992) 553-560 [discussion 621-553]
37. Shulkes A., and Read M. Regulation of somatostatin secretion by gastrin- and acid-dependent mechanisms. Endocrinology 129 (1991) 2329-2334
38. Sitcheran R., Gupta P., Fisher P.B., and Baldwin A.S. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. EMBO J 24 (2005) 510-520
39. Soloff M.S., Izban M.G., Cook Jr. D.L., Jeng Y.J., and Mifflin R.C. Interleukin-1-induced NF-kappaB recruitment to the oxytocin receptor gene inhibits RNA polymerase II-promoter interactions in cultured human myometrial cells. Mol Hum Reprod 12 (2006) 619-624
40. Suto G., Kiraly A., and Tache Y. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 106 (1994) 1568-1575
41. Suzuki T., Grand E., Bowman C., Merchant J.L., Todisco A., Wang L., et al. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1405-1412
42. Tong X., Yin L., Washington R., Rosenberg D.W., and Giardina C. The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 265 (2004) 171-183
43. Uehara A., Okumura T., Kitamori S., Takasugi Y., and Namiki M. Interleukin-1: a cytokine that has potent antisecretory and anti-ulcer actions via the central nervous system. Biochem Biophys Res Commun 173 (1990) 585-590
44. Verrecchia F., Wagner E.F., and Mauviel A. Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Rep 3 (2002) 1069-1074
45. Wallace J.L., Cucala M., Mugridge K., and Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 261 (1991) G559-564
46. Williams S.A., Chen L.F., Kwon H., Ruiz-Jarabo C.M., Verdin E., and Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25 (2006) 139-149
47. Zabaleta J., Lin H.Y., Sierra R.A., Hall M.C., Clark P.E., Sartor O.A., et al. Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis 29 (2008) 573-578
48. Zienolddiny S., Ryberg D., Maggini V., Skaug V., Canzian F., and Haugen A. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109 (2004) 353-356